🇺🇸 FDA
Pipeline program

Enoxaparin 40 mg q12h

Droege2015

Approved small_molecule completed

Quick answer

Enoxaparin 40 mg q12h for Traumatic Injury is a Approved program (small_molecule) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Traumatic Injury
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials